N. Martínez

A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study

M. Provencio, N. Martínez, M. Herrera, 2018, Clinical and Translational Oncology.

Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis.

A. González-Neira, G. Pita, A. Lluch, 2015, The oncologist.

Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial.

M. Buyse, L. Fallowfield, D. Cella, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized, phase II trial comparing continuous versus intermittent capecitabine monotherapy for metastatic breast cancer (MBC).

M. Ramos, J. García-Saenz, M. Muñoz, 2009, Journal of Clinical Oncology.

A pilot study of aerobic exercise performed in breast cancer patients during chemotherapy infusion.

S. Keteyian, J. Ehrman, E. Walker, 2010 .